NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/25/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization137,434 mln
Float2,040 mln
Earnings Date10/29/2026
EPS
4.54
Solid
P / E
14.96
Fair value
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.73
Likely reliable
1-Year Forecast
66.21
Fairly priced
Relative Strength
91
/ 100
Top performer
Business Description
Founded in 1887 and based in Princeton, New Jersey, Bristol-Myers Squibb is a global biopharmaceutical company that researches, makes, and sells medicines across a wide range of serious health conditions, including cancer, blood disorders, heart disease, and autoimmune and neurological conditions. Its portfolio includes well-known treatments such as Opdivo, Yervoy, Eliquis, and Revlimid, among many others. The company distributes its products through wholesalers, pharmacies, hospitals, and government agencies around the world.